The B3GAT3 gene plays a critical role in the biosynthesis of glycosaminoglycans, essential components of the extracellular matrix that contribute to the structural integrity of tissues and organs. Mutations in the B3GAT3 gene are associated with a rare genetic disorder characterized by multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects. This condition falls within a group of disorders known as Linkeropathy syndromes due to their association with defects in the glycosaminoglycan linkage region.
To diagnose this condition accurately, genetic testing is crucial. DNA Labs UAE offers a specialized genetic test designed to detect mutations in the B3GAT3 gene. This test is instrumental in confirming the diagnosis, enabling targeted clinical management, and providing valuable information for genetic counseling. The test cost is 4400 AED, reflecting the specialized analysis and the comprehensive insights it provides into this complex condition.
By opting for this test at DNA Labs UAE, patients and healthcare providers can expect a high level of accuracy and reliability, supported by the lab's expertise in genetic diagnostics. The results from this test can guide treatment decisions, inform about potential complications, and help in understanding the risk of recurrence in future pregnancies.
The SMAD4 Gene Myhre Syndrome Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the SMAD4 gene, which are associated with Myhre Syndrome. Myhre Syndrome is a rare genetic condition characterized by a range of symptoms including short stature, muscular build, facial dysmorphisms, and various cardiovascular and skeletal anomalies. Due to the complexity of the syndrome and its overlapping features with other conditions, genetic testing is crucial for accurate diagnosis.
This test is conducted by collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SMAD4 gene. The results from this test can provide definitive confirmation of Myhre Syndrome, enabling healthcare providers to tailor medical and developmental interventions more effectively to the needs of the patient.
The cost of the SMAD4 Gene Myhre Syndrome Genetic Test at DNA Labs UAE is 4400 AED. Given the importance of this test in the accurate diagnosis and management of Myhre Syndrome, it represents a significant step towards personalized care for patients with this rare condition.
The CENPE Gene Microcephaly Autosomal Recessive Type 13 Genetic Test is a specialized diagnostic tool designed to identify mutations in the CENPE gene, which are implicated in causing Microcephaly Autosomal Recessive Type 13. This condition is a rare genetic disorder characterized by significantly reduced head size (microcephaly) and brain size, potentially leading to developmental delays and neurological issues. The test is crucial for early diagnosis, allowing for timely intervention and support for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the CENPE gene to detect any abnormalities that could indicate the presence of the condition. The test cost is set at 4400 AED, reflecting the intricate processes and advanced technology employed to ensure accurate results. This test is essential for at-risk families, providing them with crucial information regarding their genetic health and helping them make informed decisions about their future.
CDK5RAP2 Gene Microcephaly Autosomal Recessive Type 3 Genetic Test is a specialized diagnostic assessment designed to identify mutations in the CDK5RAP2 gene, which are linked to Microcephaly Autosomal Recessive Type 3. This condition is characterized by significantly reduced head size and brain volume, potentially leading to developmental delays and neurological complications. The test is crucial for families with a history of the condition, offering insights into genetic predispositions and aiding in early intervention strategies. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this test costs 4400 AED. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic anomalies associated with the disorder. Results from this test can provide essential information for medical management, family planning, and understanding the risk of recurrence in future pregnancies.
The CDT1 gene Meier-Gorlin syndrome type 4 genetic test is a specialized diagnostic examination aimed at identifying mutations in the CDT1 gene, which are associated with Meier-Gorlin syndrome type 4. Meier-Gorlin syndrome is a rare genetic disorder characterized by short stature, small ears, and absent or underdeveloped kneecaps. Type 4 of this syndrome specifically implicates mutations in the CDT1 gene, affecting the crucial process of DNA replication and cell cycle regulation, leading to the syndrome's phenotypic manifestations.
This test is crucial for early diagnosis, allowing for appropriate management and treatment strategies to be implemented, enhancing the quality of life for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and reliability, employing advanced genetic sequencing technologies to detect mutations in the CDT1 gene.
The cost of the CDT1 gene Meier-Gorlin syndrome type 4 genetic test is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. This investment facilitates a deeper understanding of the genetic basis of the syndrome, offering affected families critical information for genetic counseling and future family planning decisions.
The "MED13L Gene Mental Retardation and Distinctive Facial Features with or without Cardiac Defects Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the MED13L gene, which are associated with a range of developmental and physical anomalies. This gene plays a crucial role in heart and brain development, and mutations can lead to intellectual disabilities, distinctive facial features, and, in some cases, congenital heart defects. The test, priced at 4400 AED, is available at DNA Labs UAE, a facility renowned for its advanced genetic testing services. By analyzing a patient's DNA, this test can confirm a diagnosis of MED13L-related syndrome, guiding treatment plans and helping families understand the risk of recurrence in future pregnancies.
The DYNC1H1 gene plays a critical role in the development and function of the nervous system. Mutations in this gene are associated with mental retardation autosomal dominant type 13 (MRD13), a condition characterized by intellectual disabilities, developmental delays, and sometimes physical abnormalities. The genetic test for MRD13, specifically targeting the DYNC1H1 gene, is a crucial diagnostic tool for individuals suspected of having this condition.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to identify mutations in the DYNC1H1 gene that are known to cause MRD13. This process helps in confirming the diagnosis, which is essential for the management and treatment of the condition. Early diagnosis can significantly improve the quality of life for individuals with MRD13 by enabling tailored educational and therapeutic interventions.
The cost of the DYNC1H1 gene mental retardation autosomal dominant type 13 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the DYNC1H1 gene. Patients and families considering this test should consult with healthcare professionals to understand its benefits and implications fully.
The "INPP5E Gene Mental Retardation Truncal Obesity Retinal Dystrophy and Micropenis Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to detect mutations in the INPP5E gene, which have been associated with a complex syndrome characterized by mental retardation, truncal obesity, retinal dystrophy, and micropenis. The condition is rare and falls under the category of ciliopathies, which are disorders related to the dysfunction of cilia, essential microscopic structures present in many cell types throughout the body.
The INPP5E gene plays a critical role in the proper functioning and structure of cilia, and mutations in this gene can disrupt cilia's role, leading to a wide range of clinical manifestations. This genetic test involves analyzing the patient's DNA to identify any mutations in the INPP5E gene that could be responsible for the syndrome's symptoms.
The test is priced at 4400 AED and is performed at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the INPP5E gene. This test is crucial for families seeking a diagnosis for symptoms related to the syndrome, as it can provide valuable information for managing the condition and understanding the genetic risks for future offspring.
The "HUWE1 Gene Mental Retardation X-Linked Syndromic Turner Type Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the HUWE1 gene, which are associated with a form of X-linked mental retardation known as Turner type syndrome. This condition primarily affects males and can lead to various developmental, cognitive, and behavioral challenges. The test involves analyzing the patient's DNA to detect any abnormalities in the HUWE1 gene that could indicate the presence of the syndrome. With a cost of 4400 AED, this genetic test provides crucial information for the accurate diagnosis and management of the condition, enabling tailored interventions and support for affected individuals and their families.
The MMP13 Gene Metaphyseal Anadysplasia Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MMP13 gene, which are known to cause Metaphyseal Anadysplasia Type 1. This rare genetic disorder is characterized by skeletal abnormalities, including short stature, bowed legs, and other bone growth irregularities that typically become apparent in early childhood. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific mutations in the MMP13 gene, offering crucial information for accurate diagnosis, management, and understanding the inheritance pattern of the condition. By confirming the presence of these mutations, healthcare providers can tailor treatment plans and offer genetic counseling to affected families, enhancing the quality of life for individuals with Metaphyseal Anadysplasia Type 1.
